Middle East & Africa Breast Adenocarcinoma Treatment Market Size & Outlook
The breast adenocarcinoma treatment market in Middle East & Africa is expected to reach a projected revenue of US$ 1,401.2 million by 2030. A compound annual growth rate of 7.9% is expected of Middle East & Africa breast adenocarcinoma treatment market from 2024 to 2030.
Revenue, 2023 (US$M)
$823.4
Forecast, 2030 (US$M)
$1,401.2
CAGR, 2024 - 2030
7.9%
Report Coverage
Middle East & Africa
Middle East & Africa breast adenocarcinoma treatment market, 2018-2030 (US$M)
Related Markets
MEA breast adenocarcinoma treatment market highlights
- The MEA breast adenocarcinoma treatment market generated a revenue of USD 823.4 million in 2023.
- The market is expected to grow at a CAGR of 7.9% from 2024 to 2030.
- In terms of segment, chemotherapy was the largest revenue generating treatment in 2023.
- Chemotherapy is the most lucrative treatment segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2023 | USD 823.4 million |
| Market revenue in 2030 | USD 1,401.2 million |
| Growth rate | 7.9% (CAGR from 2023 to 2030) |
| Largest segment | Chemotherapy |
| Fastest growing segment | Chemotherapy |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Chemotherapy |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.5% of the global breast adenocarcinoma treatment market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,585.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Breast Adenocarcinoma Treatment Market Scope
Breast adenocarcinoma treatment market segmentation & scope
End Use
Hospitals
Specialty Clinics
Others
Countries
U.S.
Canada
Mexico
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
China
Japan
India
South Korea
Australia
Thailand
Brazil
Argentina
South Africa
Saudi Arabia
UAE
Kuwait
Breast Adenocarcinoma Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa breast adenocarcinoma treatment market
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
